106 related articles for article (PubMed ID: 30534358)
1. TIPE2 acts as a biomarker for GIST risk category and suppresses the viability and invasiveness of GIST cells.
Li Z; Zhang W; Li Y; Cao S; Liu S; Ning L; Jiao X; Liu Z; Xing X; Li Y; Zhou Y
Cell Biosci; 2018; 8():62. PubMed ID: 30534358
[TBL] [Abstract][Full Text] [Related]
2. TIPE2 acts as a biomarker for tumor aggressiveness and suppresses cell invasiveness in papillary thyroid cancer (PTC).
Jia W; Li Z; Chen J; Sun L; Liu C; Wang S; Chi J; Niu J; Lai H
Cell Biosci; 2018; 8():49. PubMed ID: 30186591
[TBL] [Abstract][Full Text] [Related]
3. Targeting the WEE1 kinase strengthens the antitumor activity of imatinib via promoting KIT autophagic degradation in gastrointestinal stromal tumors.
Liu W; Zeng X; Yin Y; Li C; Yang W; Wan W; Shi L; Wang G; Tao K; Zhang P
Gastric Cancer; 2020 Jan; 23(1):39-51. PubMed ID: 31197522
[TBL] [Abstract][Full Text] [Related]
4. Secreted protein acidic and rich in cysteine-like 1 suppresses metastasis in gastric stromal tumors.
Shen C; Yin Y; Chen H; Wang R; Yin X; Cai Z; Zhang B; Chen Z; Zhou Z
BMC Gastroenterol; 2018 Jul; 18(1):105. PubMed ID: 29973149
[TBL] [Abstract][Full Text] [Related]
5. TIPE2 protein prevents injury-induced restenosis in mice.
Zhang G; Zhao L; Wang Y; Shao J; Cui J; Lou Y; Geng M; Zhang N; Chen YH; Liu S
Biochim Biophys Acta; 2015 Aug; 1852(8):1574-84. PubMed ID: 25912734
[TBL] [Abstract][Full Text] [Related]
6. Immune Negative Regulator TIPE2 Inhibits Cervical Squamous Cancer Progression Through Erk1/2 Signaling.
Huang LQ; Zheng B; He Y
Open Life Sci; 2019 Jan; 14():528-536. PubMed ID: 33817189
[TBL] [Abstract][Full Text] [Related]
7. ADRB2 Regulates the Proliferation and Metastasis of Gastrointestinal Stromal Tumor Cells by Enhancing the ETV1-c-KIT Signaling.
Chen S; Wu F; Zhang J; Zhu J; Zhou X; Zhi X
J Oncol; 2023; 2023():6413796. PubMed ID: 36778918
[TBL] [Abstract][Full Text] [Related]
8. SLITRK3 expression correlation to gastrointestinal stromal tumor risk rating and prognosis.
Wang CJ; Zhang ZZ; Xu J; Wang M; Zhao WY; Tu L; Zhuang C; Liu Q; Shen YY; Cao H; Zhang ZG
World J Gastroenterol; 2015 Jul; 21(27):8398-407. PubMed ID: 26217092
[TBL] [Abstract][Full Text] [Related]
9. TIPE2 suppresses atherosclerosis by exerting a protective effect on macrophages via the inhibition of the Akt signaling pathway.
Li D; Tan Y
Exp Ther Med; 2019 Apr; 17(4):2937-2944. PubMed ID: 30936963
[TBL] [Abstract][Full Text] [Related]
10. Involvement of Bmi-1 gene in the development of gastrointestinal stromal tumor by regulating p16
Wang JL; Wu JH; Hong C; Wang YN; Zhou Y; Long ZW; Zhou Y; Qin HS
Pathol Res Pract; 2017 Dec; 213(12):1542-1551. PubMed ID: 29042141
[TBL] [Abstract][Full Text] [Related]
11. miRNA-21 sensitizes gastrointestinal stromal tumors (GISTs) cells to Imatinib via targeting B-cell lymphoma 2 (Bcl-2).
Cao CL; Niu HJ; Kang SP; Cong CL; Kang SR
Eur Rev Med Pharmacol Sci; 2016 Sep; 20(17):3574-81. PubMed ID: 27649657
[TBL] [Abstract][Full Text] [Related]
12. Beneficial Effects of Gracillin From
Liu W; Wang Y; Chen J; Lin Z; Lin M; Lin X; Fan Y
Front Pharmacol; 2021; 12():669199. PubMed ID: 34630074
[TBL] [Abstract][Full Text] [Related]
13. The expression and clinical significance of signal transducer and activator of transcription 3, tumor necrosis factor α induced protein 8-like 2, and runt-related transcription factor 1 in breast cancer patients.
Lan D; Jin X; Li M; He L
Gland Surg; 2021 Mar; 10(3):1125-1134. PubMed ID: 33842256
[TBL] [Abstract][Full Text] [Related]
14. TIPE2 Suppresses Malignancy of Pancreatic Cancer Through Inhibiting TGFβ1 Mediated Signaling Pathway.
Feng F; Liu C; Bian H; Cai W; Zhou Y; Zhou L; Zhuang Z
Front Oncol; 2021; 11():680985. PubMed ID: 34249724
[TBL] [Abstract][Full Text] [Related]
15. Gene delivery of TIPE2 inhibits breast cancer development and metastasis via CD8
Zhang Z; Liu L; Cao S; Zhu Y; Mei Q
Mol Immunol; 2017 May; 85():230-237. PubMed ID: 28314212
[TBL] [Abstract][Full Text] [Related]
16.
Yuan J; Kihara T; Kimura N; Yamasaki T; Yoshida M; Isozaki K; Ito A; Hirota S
Oncol Lett; 2022 Mar; 23(3):86. PubMed ID: 35126728
[TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal stromal tumor versus intra-abdominal fibromatosis of the bowel wall: a clinically important differential diagnosis.
Yantiss RK; Spiro IJ; Compton CC; Rosenberg AE
Am J Surg Pathol; 2000 Jul; 24(7):947-57. PubMed ID: 10895817
[TBL] [Abstract][Full Text] [Related]
18. Helpful parameter for malignant potential of gastrointestinal stromal tumors (GIST).
Wang X; Mori I; Tang W; Utsunomiya H; Nakamura M; Nakamura Y; Zhou G; Kennichi K
Jpn J Clin Oncol; 2002 Sep; 32(9):347-51. PubMed ID: 12417600
[TBL] [Abstract][Full Text] [Related]
19. Implication of TIPE2 Expression on the Malignant Transformation of Oral Leukoplakia.
Chen H; Pei M; Shin SW; Moon S; Nam W; Zheng Z
Anticancer Res; 2023 Nov; 43(11):4937-4946. PubMed ID: 37909982
[TBL] [Abstract][Full Text] [Related]
20. Gastrointestinal stromal tumors in Iceland, 1990-2003: the icelandic GIST study, a population-based incidence and pathologic risk stratification study.
Tryggvason G; Gíslason HG; Magnússon MK; Jónasson JG
Int J Cancer; 2005 Nov; 117(2):289-93. PubMed ID: 15900576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
